Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization

Summary

Eupraxia Pharmaceuticals announced the appointment of three industry leaders—Robert Bazemore, Amy Pott, and Dr. Helen Thackray—to its Board of Directors to strengthen governance and commercialization expertise.